Indexed by:
Abstract:
Mutations in and dysregulation of long non-coding RNAs (lncRNAs) are closely associated with the development of various human complex diseases, but only a few lncRNAs have been experimentally confirmed to be associated with human diseases. Predicting new potential lncRNA-disease associations (LDAs) will help us to understand the pathogenesis of human diseases and to detect disease markers, as well as in disease diagnosis, prevention and treatment. Computational methods can effec-tively narrow down the screening scope of biological experi-ments, thereby reducing the duration and cost of such experiments. In this review, we outline recent advances in computational methods for predicting LDAs, focusing on LDA databases, lncRNA/disease similarity calculations, and advanced computational models. In addition, we analyze the limitations of various computational models and discuss future challenges and directions for development.
Keyword:
Reprint Author's Address:
Email:
Source :
DRUG DISCOVERY TODAY
ISSN: 1359-6446
Year: 2023
Issue: 2
Volume: 28
7 . 4 0 0
JCR@2022
ESI Discipline: PHARMACOLOGY & TOXICOLOGY;
ESI HC Threshold:14
Cited Count:
WoS CC Cited Count: 11
SCOPUS Cited Count: 10
ESI Highly Cited Papers on the List: 0 Unfold All
WanFang Cited Count:
Chinese Cited Count:
30 Days PV: 7
Affiliated Colleges: